EXCITING HIGHLIGHTS FROM EWMA 2024!



Event
DEBx Medical is proud to share the highlights from our presence at the EWMA (European Wound Management Association) Conference in London! The event was a resounding success, filled with engaging symposiums, insightful booth talks, and dynamic interactions with clinicians, distributors, and partners from around the globe. Attendees experienced firsthand how DEBRICHEM® is revolutionizing wound care.
Watch our after-movie and immerse yourself in the energy of this incredible event.

Company Dinner
We had the pleasure of hosting an exclusive dinner with over 70 guests from 18 nationalities. This diverse gathering showcased the global reach and impact of DEBRICHEM®. The evening was a fantastic opportunity to connect, share experiences, and celebrate our collective achievements in wound care.

HOW DEBRICHEM® WORKS

DEBRICHEM® desiccates the biofilm, as well as the residing and planktonic micro-organisms within 60 seconds of application.
By instantly capturing water molecules from any type of exposed biological material, DEBRICHEM® has an immediate dehydrating effect, with no damage to the vital tissue below the wound bed.

VIDEO 1: DEBRICHEM® mode of action on animated wound model
VIDEO 2: DEBRICHEM®'s effect on bacteria
VIDEO 3: DEBRICHEM® safe on intact skin
VIDEO 4: DEBRICHEM® application process

TESTIMONIALS

LISTEN TO WHAT DEBRICHEM® USERS SAY
  • "Biofilm is an enemy to wound healing. Imagine working on a Monday morning in a clinic setting where workload is way out of hand, and you have a patient that needs for a debridement but you are not free to do so, patient has high risk of bleeding and cannot tolera- te pain that well, but you still need to remove the biofilm and bioburden.

    What's the quickest and fastest way without compromising the good tissues? DEBRICHEM® by DEBX Medical is the answer. With a few drops from 'heaven; your biofilm eradication works like magic. Even fairy godmother won't be able to do this trick that fast. Surely the result will stun you.

    Furthermore, it reduces your time to attend to patient, reduces the cost of patient's visit, no hospitalization, no bleeding and definitely, a fast desirable outcome."
    Dr. HELMI RASHIDI
    Head of of Wound Care Unit Hospital Ampang Malaysia
  • "Some infected wounds are difficult to debride without taking the patient to the OR.
    Where there is exuberant lumpy bumpy irregular granulation tissue for example.

    In my experience one application of DEBRICHEM® will completely solve that problem.
    By the next week you will be left with a perfectly healthy wound bed."
    Professor Steven Jeffery
    Medical Director Pioneer Sussex Wound Healing and Lymphoedema Centres
  • The presence of infection and biofilm is a major obstacle to healing, slowing or preventing wound healing, requiring extensive debridement of the affected tissue with additional problems such as aggression of healthy tissue, pain, repeated procedures and added costs of operating theatre, diagnostic tests, local treatment and other procedures.

    The availability of DEBRICHEM® has allowed us to quickly and cost-effectively address the removal of biofilm and infected tissue, facilitating optimal wound bed preparation for early application of other advanced therapies such as grafts or advanced healing products that reduce the time to closure of complex wounds.

    It has also allowed us to rationalise the use of antibiotics and avoid the risk of antibiotic resistance and other problems related to antibiotic treatments.
    Dr. Joan Enric Torra i Bou
    Clinical Consultant and researcher. Doctorate Programme in Health Sciences, Universitat de Lleida, Lleida, Spain.
    Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IrisCC), Vic.
    Barcelona, Spain
  • "I've been trying DEBRICHEM® on patients with diabetic foot emergencies (foot attack) with necrotizing fasciitis and who are also septic.

    What I have observed so far is the rapid control of the local infection and the early appearance of healthy granulation tissue."
    H.Erhan Güven,M.D.
    Assoc.Prof.of Surgery
    Chief Physician, General Hospital, Ankara Etlik City Hospital
    Director, Chronic Wounds and Diabetic Foot Department, Ankara Etlik City Hospital

15TH ABU DHABI WOUND CARE CONFERENCE


We're proud to share a glimpse of the memorable moments from our recent scientific event and company dinner during the 15th Abu Dhabi Wound Care Conference!
From engaging scientific presentations to delightful networking opportunities, the event was an absolute success! We had the privilege of hosting esteemed clinicians and experts in wound care, coming together to exchange insights, share experiences, and foster collaboration.
A special thanks to all our attendees for making the evening truly unforgettable. Your presence and participation contributed to the vibrant atmosphere and lively discussions throughout the event.
Missed out on the action? Stay tuned for more exciting updates and future events! Together, we're shaping the future of wound care and making a difference in patient lives.

DEBRICHEM®

APPLICATION PROCESS

REMOVES BIOFILM & INFECTION


DEBRICHEM® offers a straightforward and fast application process suitable for ambulatory settings, making it accessible for healthcare professionals: doctors and nurses. Unlike traditional debriding methods, it doesn’t require a specific training.

Treating Wound Infections Without Antibiotics

Dr. Hajnal-Gabriela Illes
Infectious disease specialist, wound care specialist
Clinique de Augustine, France
Developing a Clinical Pathway with DEBRICHEM®
DEBRICHEM® as a debridement option in the podiatry clinic.

Andrew Sharpe
Advanced Podiatrist
Northern Care Alliance NHS Foundation Trust, UK
TOPICAL USE OF DEBRICHEM®
FOR THE TREATMENT OF PERIUNGUAL SKIN LESIONS POST-PHENOLIZATION: A CASE SERIES

Dr. Alberto Cogo, MD PhD
Head of Vascular Medicine
Villa Berica Hospital , Vicenza - Italy
Pain reception and management during the usage of DEBRICHEM®

Dr. Polina Shabes
Assistant Physician In The Vascular Surgery Department
Dept. for Vascular and Endovascular Surgery, University Hospital Düsseldorf, Germany
DEBRICHEM®: Biofilm disruption through chemical debridemnet

Joan-Enric Torra i Bou
Advanced Nursing & Sapiens FHW Consultant
Sapiens Ferides, Heridas, Wound Consultants, Spain
DEBRICHEM® Wound Debridement
Integrating a Chemical Debridement Into a Clinical Pathway

Prof Steven Jeffery
Consultant Burns and Plastic Surgeon
Medical Director, Pioneer Wound Clinics
DEBRICHEM® in the EMERGENCY SURGICAL TREATMENT of DIABETIC FOOT ATTACK with NECROTIZING FASCIITIS.

Dr. Hikmet Erhan Güven
Director of General Surgery - Diabetic Foot and Chronic Wounds Department
Ankara Etlik City (General) Hospital, Turkye
A Parisian Case series on DEBRICHEM® use in French market; the benefits and challenges.

Dr. Vanessa Milongo
Vascular Doctor
Grand Hospital Paris St. Joseph, France
EFFICACY OF CHEMICAL DEBRIDEMENT AGENT ON A HUMAN EXPLANT MODEL INFECTED BY BIOFILM

Hans-Pieter Snels
Clinical and Product Director
DEBx Medical, The Netherlands

CONTACT DEBx MEDICAL

Want to know more about our product portfolio or have any questions?
Get in touch with us!





    By clicking on "submit query", I confirm that I have read, understood and agree to the privacy policy of this website.

    By clicking on "submit query", I confirm that I have read, understood and agree. to the privacy policy of this website.




    OUR TEAM CAN'T WAIT TO CONNECT WITH YOU
    AND PROVIDE THE INFORMATION YOU NEED